Skip to main content
We use the device to hit the primary tumor hard,” said Dr. Jen Jen Yeh. “There is so little systemic toxicity that it leaves room to administer additional drugs against cancer cells that may have spread in the rest of the bod|Joseph M. DeSimone, PhD, is the Chancellor’s Eminent Professor of Chemistry in UNC’s College of Arts and Sciences and William R. Kenan, Jr. Distinguished Professor of Chemical Engineering at NC State University

February 8, 2016

Device hits pancreatic tumors hard with toxic four-drug cocktail, sparing the body

A new implantable device delivers first-line treatment for pancreatic cancer directly to tumors, bypassing bloodstream and limiting widespread side effects. A team of researchers from the University of North Carolina including Drs. Jen Jen Yeh and Joseph DeSimone, has shown in preclinical research that the device can deliver a particularly toxic dose of drugs directly to pancreatic tumors to stunt their growth or, in some cases, shrink them. This approach would also spare the patient toxic side effects.

February 2, 2016

Zika, emerging viruses focus of UNC virology seminar

Zika, the virus currently causing worldwide concern due to its alarming connection to a neurological birth disorder, was discussed as part of a presentation on emerging infectious diseases for the UNC Lineberger-led seminar series titled "Virology in Progress." Helen Lazear, PhD, a UNC Lineberger member and an assistant professor in the UNC School of Medicine Department of Microbiology and Immunology, spoke about Zika and noted that experts know relatively little about the virus.

Matt Nielsen, MD, MS, is a UNC Lineberger member, co-director of the Multidisciplinary Urologic Oncology Program and associate professor of urology in the UNC School of Medicine.

February 1, 2016

Physicians issue advice, raise questions about evaluating blood in the urine as a cancer sign

A new report from the American College of Physicians’ High Value Care Task Force issues advice for physicians on how to detect and evaluate blood found in the urine, which is known as hematuria. The report, which was first-authored by UNC Lineberger Comprehensive Cancer Center member Dr. Matthew Nielsen, also raises questions about the potential harms associated with diagnostic tests that are commonly employed to evaluate this condition.

January 29, 2016

Oncology Nursing Society honors three UNC nurses with national awards

Each year, the Oncology Nursing Society (ONS), the nation’s largest professional association of more than 35,000 oncology nurses, grants prestigious recognition to oncology nurses, researchers, and employers who are changing lives and bettering their profession. The organization recently announced that three UNC oncology nurses have been honored for their career achievements and outstanding contributions to cancer care.